INTRODUCTION Atopic dermatitis (AD) is an inflammatory skin disease marked by intense pruritus, impaired skin barrier function, and recurrent flares.1 Its prevalence in the United States is estimated to range…
Read More
To the Editor, Rosacea is a chronic inflammatory disorder primarily affecting the face, characterized by erythema, telangiectasia, inflammatory lesions, and flushing.1 Rosacea affects up to 10% of the global population…
Read More
INTRODUCTIONMelanoma is the leading cause of skin cancer-related mortality worldwide.¹ Advances in anti-programmed cell death protein 1 (PD-1) therapies, such as pembrolizumab, have significantly improved survival outcomes in advanced melanoma.²…
Read More
INTRODUCTIONMelasma is a frequent chronic pigmentary condition that is resistant to treatment, most commonly affecting Fitzpatrick skin types III to V.1 Worldwide, melasma is one of the most prevalent dermatoses,…
Read More
INTRODUCTIONNonmelanoma skin cancer is the most common form of cancer, with cutaneous squamous cell carcinoma (SCC) accounting for more than 20% of all skin cancers.1,2 Although historically less prevalent than…
Read More
INTRODUCTIONThe primary goal of a skin cleanser is to remove surface dirt, sweat, sebum, and contaminants without irritating or drying the skin. The key ingredients in cleansers include surfactants for…
Read More
INTRODUCTIONCutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, with increasing incidence rates worldwide.1 While most cases are successfully treated with surgical excision or radiation therapy, a…
Read More
INTRODUCTIONNecrotizing fasciitis is an uncommon but potentially rapidly fatal infection. The mortality rate is estimated to be 23-29%1 and when it affects the limbs, the amputation rate is 11-14%.1 There…
Read More
INTRODUCTIONMalassezia folliculitis (MF) is a lipid-dependent fungus that thrives on the lipid composition of sebum in the sebaceous glands of hair follicles and the stratum corneum.1,2 Malassezia was previously referred…
Read More
INTRODUCTIONPsoriasis is a chronic immune-mediated inflammatory disease driven by dysregulated interleukin-17 (IL-17) signaling across skin and musculoskeletal tissues. While upstream IL-23 inhibition and selective IL-17 cytokine blockade have improved outcomes,…
Read More
In this issue:Clinical and Real-World Implications of IL-17 Receptor Blockade in Plaque Psoriasis and Psoriatic Arthritis With BrodalumabBrodalumab is a fully human monoclonal antibody targeting interleukin-17 receptor A (IL-17RA), providing…
Read More
INTRODUCTIONThis is the first study to examine HPV vaccination rates, protective equipment use, and self-reported health outcomes among dermatologic surgeons in the context of surgical plume exposure. Dermatologists routinely perform…
Read More
